Igal Kushnir

Original Research

Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

07/02/2018

Keyur Patel ;

Maria A. Kasper ;

Igal Kushnir ;

Marissa J. Carter , PhD;

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Alon Kushnir ;

This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).

This pilot study evaluates...

07/02/2018

Wounds

Original Research

Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study

09/13/2016

Igal Kushnir ;

Alon Kushnir ;

Thomas E. Serena , MD, FACS, FACHM, MAPWCA;

Doron Garfinkel ;

09/13/2016

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Igal Kushnir

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products